Drugs in modern resuscitation

British Journal of Anaesthesia

Volumn 79, Issue 2, 1997, Pages 188-197

  Vincent, R ^a,b  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATROPINE; BICARBONATE; BRETYLIUM; CALCIUM; CATECHOLAMINE DERIVATIVE; HYPERTENSIVE FACTOR; LIDOCAINE; MAGNESIUM;

ACIDOSIS; CARDIOPULMONARY ARREST; DEFIBRILLATION; HEART ARREST; HEART CONDUCTION; HEART MASSAGE; HEART MUSCLE EXCITABILITY; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPOXIA; INTRACARDIAC DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORGAN PERFUSION; PRIORITY JOURNAL; RESUSCITATION; REVIEW;

EID: 0030792185     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/79.2.188     Document Type: Review

References (150)

1. Adrogue HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood. New England Journal of Medicine 1989; 320: 1312-1316.
2. Advanced Life Support Committee of the European Resuscitation Council. Management of peri-arrest arrhythmias. Resuscitation 1994; 28: 151-159.
3. Advanced Life Support Working Party of the European Resuscitation Council. Guidelines for advanced life support. Resuscitation 1992; 24: 111-122.
4. American Heart Association. Textbook of Advanced Cardiac Life Support. Dallas: American Heart Association, 1987.
5. Anderson JL. Antifibrillatory versus antiectopic therapy. American Journal of Cardiology 1984; 54: 7-13A.
6. Antman EM. Randomised trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. American Journal of Cardiology 1995; 75: 391-393.
7. 3 in experimental lactic acidosis in dogs. American Journal of Physiology 1982; 242: F586-F591.
8. Arsenian MA. Magnesium and cardiovascular disease. Progress in Cardiovascular Disease 1993; 35: 271-310.
9. Babbs CF, Yim GKW, Whistler SJ, Tacker WA, Geddes LA. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. American Heart Journal 1979; 98: 345-350.
10. Barsan WG, Levy RC, Weir H. Lidocaine levels during CPR: differences after peripheral venous, central venous, and intracardiac injections. Annals of Emergency Medicine 1981; 10: 73-78.
11. Berenyi KJ, Wolk M, Killip T. Cerebrospinal fluid acidosis complicating therapy of experimental cardiopulmonary arrest. Circulation 1975; 52: 319-324.
12. Bircher N, Safar P. Cerebral preservation during cardiopulmonary resuscitation. Critical Care Medicine 1985; 13: 185-190.
13. Bircher NG. Cardiopulmonary cerebral resuscitation: brain resuscitation, mediators, glucose, and anesthetics. Current Opinion in Anesthesiology 1990; 3: 259-264.
14. 2; and osmolality. Journal of the American Medical Association 1976; 235: 506-509.
15. Bleske BE, Warren EW, Rice TL, Shea MJ, Amidon G, Knight P. Comparison of intravenous and intranasal administration of epinephrine during CPR in a canine model. Annals of Emergency Medicine 1992; 21: 1125-1130.
16. Brown CG, Davis EA, Werman HA, Hamlin RL. Methoxamine versus epinephrine on regional cerebal flow during cardiopulmonary resuscitation. Critical Care Medicine 1987; 15: 682-686.
17. Brown CG, Martin DR, Pepe P, Stueven H, Cummins RO, Gonzalez E, Jastremski M, and the High-dose Epinephrine Study Group. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. New England Journal of Medicine 1992; 327: 1051-1055.
18. Brown CG, Werman HA. Adrenergic agonists during cardiopulmonary resuscitation. Resuscitation 1990; 19: 1-16.
19. Brown CG, Werman HA, Davis EA, Hamlin RL, Hobson J, Ashton JA. Comparative effect of graded doses of epinephrine on regional brain blood flow during CPR in a swine model. Annals of Emergency Medicine 1986; 15: 1138-1144.
20. Brown CG, Werman HA, Davis EA, Katz S, Hamlin RL. The effect of high-dose phenylephrine versus epinephrine on regional cerebal blood flow during CPR. Annals of Emergency Medicine 1987; 16: 743-748.
21. Brown C, Wiklund L, Bar-Joseph G, Miller B, Bircher N, Paradis N, Menegazzi J, von Planta M, Kramer GC, Gisvold S-E. Future directions for resuscitation research. IV. Innovative advanced life support pharmacology. Resuscitation 1996; 33: 163-177.
22. Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. Journal of the American Medical Association 1992; 268: 2667-2672.
23. Capparelli EV, Chow MSS, Kluger J, Fieldman A. Differences in systemic and myocardial blood acid-base status during experimental resuscitation. Critical Care Medicine 1989; 17: 442-446.
24. Chamberlain DA. Lignocaine and bretylium as adjuncts to electrical defibrillation. Resuscitation 1991; 22: 153-157.
25. Chow MSS, Kluger J, DiPersio DM, Lawrence R, Fieldman A. Antifibrillatory effects of lidocaine and bretylium immediately post cardiopulmonary resuscitation. American Heart Journal 1985; 110: 938-943.
26. Chow MSS, Kulger J, Lawrence R, Fieldman A. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proceedings of the Society of Experimental Biology and Medicine 1986; 182: 63-67.
27. Cohn JD, Del Guercio LRM, Feins NR, Coomarawamy RP, Mantel L. Cardiorespiratory determinants of clinical resuscitation. Surgical Forum 1965; 16: 182-184.
28. Collinsworth KA, Kalman SA, Harrison DC. The clinical pharmacology of lidocaine as an antiarrhythmic drug. Circulation 1974; 50: 1217-1222.
29. Crile GW, Dolley DH. An experiemental research into the resuscitation of dogs killed by anaesthetics and asphyxia. Journal of Experimental Medicine 1906; 8: 713-715.
30. Dauchot P, Gravenstein JS. Bradycardia after myocardial ischemia and its treatment with atropine. Anesthesiology 1976; 44: 501-518.
31. Ditchey RV, Lindfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988; 78: 382-389.
32. Ditchey RV, Winkler JV, Rhodes CA. Relative lack of coronary blood flow during closed-chest resuscitation in dogs. Circulation 1982; 66: 297-302.
33. Dorian P, Fain ES, Davy J-M, Winkle RA. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. Journal of the American College of Cardiology 1986; 8: 327-332.
34. Dorian P, Fain ES, Davy J-M, Winkle RA. Effect of quinidine and bretylium on defibrillation energy requirements. American Heart Journal 1986; 121: 19-24.
35. Downey JM, Chagrasulis RW, Hemphill V. Quantitive study of intramyocardial compression in the fibrillating heart. American Journal of Physiology 1979; 237: H191-H196.
36. Dronen S, Thompson B, Nowak R, Tomlanovich M. Subclavian vein catheterization during cardiopulmonary resuscitation: a prospective comparison of the supraclavicular and infraclavicular percutaneous approaches. Journal of the American Medical Association 1982; 247: 3227-3230.
37. Dybvik T, Strand T, Sleen PA. Buffer therapy during out-of-hospital cardiopulmonary resuscitation. Resuscitation 1995; 29: 89-95.
38. Echt DS, Black JN, Barbey JT, Coxe DR, Cato E. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Circulation 1989; 79: 1106-1117.
39. Edmonds-Seal J. Acid-base studies after cardiac arrest. A report of 64 cases. Acta Anaesthesiologica Scandanavica 1966; 23 (Suppl.): 235-241.
40. Edvinson L, Lacome P, Owman CH, Reynier-Rebuffel AM, Seylaz J. Quantitative changes in regional cerebal blood flow of rats induced by alpha-and beta-adrenergic stimulants. Acta Physiologica Scandinavica 1979; 197: 289-296.
41. Eisenhauer ED, Derveloy RJ, Hastings PR. Prospective evaluation of central venous pressure (CVP) catheters in a large city-county hospital. Annals of Surgery 1982; 196: 560-564.
42. Eleff SM, Schleien CL, Koehler RC, Schffner DH, Tsitlik J, Halperin HR, Rogers MC, Traystman RJ. Brain bio-energetics during cardiopulmonary resuscitation in dogs. Anethesiology 1992; 76: 77-84.
43. Emergency Cardiac Care Committee and Subcommittee of the American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Journal of the American Medical Association 1992; 268: 2171-2295.
44. Emerman CL, Bellon EM, Lukens TW, May TE, Effron D. A prospective study of fermoral versus subclavian vein catheterization during cardiac arrest. Annals of Emergency Medicine 1990; 19: 26-30.
45. Emerman CL, Pinchak AC, Hancock D, Hagen JF. Effect of injection site on circulation times during cardiac arrest. Crtical Care Medicine 1988; 16: 1138-1141.
46. Euler DE, Zeman TW, Wallock ME, Scanlon PJ. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation. American Heart Journal 1986; 112: 25-31.
47. Fiser DH. Intraosseous infusion. New England Journal of Medicine 1990; 322: 1579-1581.
48. Foley PJ, Tacker WA, Wortsman J, Frank S, Cryer PE. Plasma catecholamine and serum Cortisol responses to experimental cardiac arrest in dogs. American Journal of Physiology 1987; 253: E283-E289.
49. Follette DM, Fey K, Buckberg GD, Helly JJ, Steed DL, Foglia RP, Maloney JV. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. Journal of Thoracic and Cardiovascular Surgery 1981; 82: 221-238.
50. Gazmuri RJ, von Planta M, Weil MH, Rackow EC. Cardiac effects of carbon dioxide consuming and carbon dioxide-generating buffers during cardiopulmonary resuscitation. Journal of the American College of Cardiology 1990; 15: 482-490.
51. Gibbs CL, Papadoyannis DE, Drake AJ, Noble MI. Oxygen consumption of the nonworking and potassium chloride-arrested dog heart. Circulation Research 1980; 47: 408-417.
52. Gonzalez ER, Ornato JP, Garnett AR, Levine RL, Young DS, Racht EM. Dose-dependent vasopressor response to epinephrine during CPR in human beings. Annals of Emergency Medicine 1989; 18: 920-926.
53. Graf H, Arieff AI. The use of sodium bicarbonate in the therapy of organic acidosis. Intensive Care Medicine 1986; 12: 285-288.
54. Grundler W, Weil MH, Rackow EC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation 1986; 74: 1071-1074.
55. Guerci AD, Chandra N, Johnson E, Rayburn B, Wurmb E, Tsitlik J, Halperin HR, Siu C, Weisfeldt ML. Failure of sodium bicarbonate to improve resuscitation from ventricular fibrillation in dogs. Circulation 1986; 74 (Suppl. IV): 75-79.
56. Hasegawa EA. The endotracheal use of emergency of drugs. Heart and Lung 1986; 15: 60-63.
57. Haynes RE, Chinn TL, Copass MK, Cobb LA. Comparison of bretylium tosylate and lidocaine in management of out-of-hospital ventricular fibrillation: A randomized clinical trial. American Journal of Cardiology 1981; 48: 353-356.
58. Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Lindkvist J, Persson NG, Holmberg S. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? Resuscitation 1997; 33: 199-205.
59. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Archives of Internal Medicine 1989; 149: 2694-2698.
60. Hollifield JW. Potassium and magnesium abnormalities: Diuretics and arrhythmias in hypertension. American Journal of Medicine 1984; 77: 28-32.
61. Jackson RE, Joyce K, Danosi SF, White BC, Vigor D, Hoehner TJ. Blood flow in the cerebal cortex during cardiac resuscitation in dogs. Annals of Emergency Medicine 1984; 13: 657-659.
62. Jaffe AS. The use of anti-arrhythmics in advanced cardiac life support. Annals of Emergency Medicine 1993; 22: 307-316.
63. Januszewicz W, Sznajderman M, Ciswicka-Sznajderman M, Wocial B, Rymaszewski Z. Plasma free fatty acid and catecholamine levels in patients with acute myocardial infarction. British Heart Journal 1971; 33: 716-718.
64. Jude JR, Kouwenhoven WB, Knickerboker GG. External cardiac resuscitation. Monographs on Surgical Science 1964; 1: 59-117.
65. Keats S, Jackson RE, Kosnik JW, Tworek RM, Freeman SB. Effect of peripheral versus central injection of epinephrine on changes in aortic diastolic blood pressure during closed-chest massage in dogs. Annals of Emergency Medicine 1985; 14: 495.
66. Kerber RE, Pandian NG, Jensen SR, Constantin L, Kieso RA, Melton J, Hunt M. The effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. Journal of the American College of Cardiology 1986; 7: 397-405.
67. Kern KB, Elchisak MA, Sanders AB, Badylak SF, Tacker WA, Ewy GA. Plasma catecholamines and resuscitation from prolonged cardiac arrest. Critical Care Medicine 1989; 17: 786-791.
68. Kette F, Weil MH, Gazmuri RJ. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion pressure. Journal of the American Medical Association 1991; 266: 212-216.
69. Kette F, Weil MH, von Planta M, Gazmuri RJ, Rackow EC. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation 1990; 81: 1660-1666.
70. 2 and its relationship to myocardial pH after regional coronary coclusion in the dog. Circulation Research 1985; 56: 537-547.
71. Kindig NB, Filley GF. Intravenous bicarbonate may cause transient intracellular acidosis. Chest 1983; 83: 712.
72. Kirimli B, Harris LC, Safar P. Evaluation of sodium bicarbonate and epinephrine in cardiopulmonary resuscitation. Anesthesia and Analgesia 1969; 48: 649-658.
73. Kline BS, Winternitz MC. Studies upon experiemental pneumonia in rabbits. VIII. Intra vitam staining in experiemental pneumonia and the circulation in the pneumonic lung. Journal of Experimental Medicine 1915; 21: 311-319.
74. Klocke FJ, Kaiser GA, Ross J, Braunwald E. Mechanism of increase of myocardial oxygen uptake produced by catecholamines. American Journal of Physiology 1965; 209: 913-918.
75. Kloek W, Cummins R, Chamberlain DA, Bossaert L, Callanan V, Carli P, Christenson J, Connolly B, Ornato J, Sanders A, Steen P. The universal ALS algorithm. An advisory statement by the Advanced Life Support Working Group of the International Liaison Committee on Resuscitation. Resuscitation 1997; 34: 109-111.
76. Koehler RC, Micheal JR, Guerci AD, Chandra N, Schleien CL, Dean JM, Rogers MC, Weisfeldt ML,Traystman RJ. Beneficial effect of epinephrine infusion on cerebal and myocardial blood flows during CPR. Annals of Emergency Medicine 1985; 14: 744-749.
77. Koo CC, Allen JD, Pantridge JF. Lack of effect of bretylium on electrical defibrillation in a controlled study. Cardiovascular Research 1984; 18: 762-767.
78. Kosnik JW, Jackson RE, Keats S, Tworek RM, Freeman SB. Dose-related response of centrally administered epinephrine on the change in aortic diastolic pressure during closed-chest massage in dogs. Annals of Emergency Medicine 1985; 14: 204-208.
79. Koster RW. Lidocaine: work still in progress. Resuscitation 1997; 33: 197-198.
80. Koster RW, Dunning AJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the perhospital phase of acute myocardial infarction. New England Journal of Medicine 1985; 313: 1105-1110.
81. Kowey PR, Marinchak RA, Rials SJ, Rubin AM, Smith L. Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias. American Heart Journal 1993; 125: 1628-1632.
82. Kuhn GJ, White BC, Swetnam RE, Mumey JF, Rydesky MF, Tintinalli JE, Krome RL, Hoehner PJ. Peripheral versus central circulation time during CPR: a pilot study. Annals of Emergency Medicine 1981; 10: 417-419.
83. Ledingham IMCA, Norman JN. Acid-base studies in experimental cardiac arrest. Lancet 1962; 2: 967-969.
84. Lee SK, Vaagenes P, Safar P, Stezoski WS, Scanlon M. Effect of cardiac arrest time on cortical cerebral blood flow during subsequent standard external cardiopulmonary resuscitation in rabbits. Resuscitation 1989; 17: 105-117.
85. Leveque PE. Antiarrhythmic action of bretylium. Nature (London) 1965; 207: 203-204 .
86. Li Y-C, Wiklund L, Bjerneroth G. Influence of alkaline buffers on cytoplasmic pH in myocardial cells exposed to hypoxia. Resuscitation 1997; 34: 71-77.
87. Lindner KH, Ahnfeld FW, Grunert A. Epinephrine versus norepinephrine in prehospital ventricular fibrillation. American Journal of Cardiology, 1991; 67: 427-428.
88. Lindner KH, Ahnefeld FW, Prengel AW. Comparison of standard and high dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anesthesiologica Scandinavica 1991; 35: 253-256.
89. Lippestad CTh, Forfang K. Production of sinus arrest by lignocaine. British Medical Journal 1971; 1: 537.
90. Little RA, Frayn KN, Randall PE, Stoner HB, Morton C, Yates DW, Laing GS. Plasma catecholamines in the acute phase of the response to myocardial infarction. Archives of Emergency Medicine 1986; 3: 20-27.
91. Little RA, Frayn KN, Randall PE, Stoner HB, Yates DW, Laing GS, Kumar S, Banks JM. Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Quarterly Journal of Medicine 1985; 214: 133-140.
92. Livesy JJ, Follette DM, Fey KH, Nelson RL, DeLand EC, Bardard RJ, Buckberg GD. Optimizing myocardial supply/demand balance with alpha-adrenergic drugs during cardiopulmonary resuscitation. Journal of Thoracic and Cardiovascular Surgery 1978; 76: 244-251.
93. Mace SE. Effect of technique of administration on plasma lidocaine levels. Annals of Emergency Medicine 1986; 15: 552-556.
94. MacGregor DC, Wilson GJ, Holness DE, Lixfield W, Yasui H, Tanaka S, Silver MD, Gunstensen J. Intramyocardial carbon dioxide tension: A guide to the safe period of anoxic arrest of the heart. Journal of Thoracic and Cardiovascular Surgery 1974; 68: 101-107.
95. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. Journal of the American Medical Association 1988; 260: 1910-1916.
96. Marsh JD, Margolis TI, Kim D. Mechanisms of diminished contractile response to catacholamine during acidosis. American Journal of Physiology 1988; 254: H20-H27.
97. Martin GB, O'Brien JF, Best R, Goldman J, Tomlanovich MC, Nowak RM. Insulin and glucose levels during CPR in the canine model. Annals of Emergency Medicine 1985; 14: 293-297.
98. Micheal JR, Guerci AD, Koehler RC, Shi A-Y, Tsitlik J, Chandra N, Niedermeyer E, Rogers MC, Traystman RJ, Weisfeldt ML. Mechanisms by which epinephrine augments cerebal and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984; 69: 822-835.
99. Monroe RG, French G. Ventricular pressure-volume relationships and oxygen consumption in fibrillation and arrest. Circulation Research 1960; 8: 260-266.
100. Murphy KM, Caplen SM, Nowak RM, Lin WN, Kelly AR, Slocombe R, Tomlanovich MC. Endotrachcal bretylium tosylate in a canine model. Annals of Emergency Medicine 1984; 13: 87-91.
101. Nalos PC, Ismail Y, Pappas JM, Nyitray W, DonMichael TA. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. American Heart Journal 1991; 122: 1629-1632.
102. Neimann JT. Differences in cerebral and myocardial perfusion during closed chest resuscitation. Annals of Emergency Medicine 1984; 13: 849-853.
103. Neimann JT, Criley JM, Rosborough JP, Niskanen RA, Alferness C. Predictive indicies of successful cardiac resuscitation after prolonged arrest and experimental cardiopulmonary resuscitation. Annals of Emergency Medicine 1985; 14: 521-528.
104. Ng ML, Levy MN, DeGeest H, Zieske H. Effects of myocardial hypoxia on left ventricular performance. American Journal of Physiology 1966; 211: 43-50.
105. Nowak RM, Bodnar TJ, Dronen S, Gentzkow G, Tomlanovich MC. Bretylium tosylate as an initial treatment for cardiopulmonary arrest: a randomized comparison with placebo. Annals of Emergency Medicine 1981; 10: 404-407.
106. Olson DW, Thompson BM, Darin JC, Milbrath MH. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of hospital ventricular fibrillation in a paramedic system. Annals of Emergency Medicine 1984; 13: 807-810.
107. Orlowski JP, Porembka DT, Gallagher JM, Lockrem JD, Van Lente F. Comparison study of intraoseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Amerian Journal of Diseases of Childhood 1990; 144: 112-117.
108. Ornato JP, Gonzalez ER, Jaffe AS. Use of cardiovascular drugs during cardiopulmonary resuscitation. In: Messerli FH, ed. Cardiovascular Drug Therapy, 2nd Edn. Philadelphia: WB Saunders, 1996; 206-224.
109. Ornato JP, Gondalez ER, Coyne MR, Beck CL, Collins MS. Arterial pH in out-of-hospital cardiac arrest: response time as a determinant of acidosis. American Journal of Emergency Medicine 1985; 3: 498-502.
110. O'Rourke GW, Greene NM. Autonomic blockade and the resting heart rate in man. American Heart Journal 1970; 80: 469-474.
111. Otto CW, Yakaitas RW. The role of epinephrine in CPR: a reappraisal. Annals of Emergency Medicine 1984; 13: 840-843.
112. Paradis NA, Martin GB, Rivers EP, Goetting MG, Appleton TJ, Feingold M, Nowak RM. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. Journal of the American Medical Association 1990; 263: 1106-1113.
113. Paradis NA, Martin GB, Rosenberg J, Rivers EP, Goetting MG, Appleton TJ, Feingold M, Cryer PE, Wortsman J, Nowak RM. The effect of standard-and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. Journal of the American Medical Association 1991; 265: 1139-1144.
114. Patterson E, Eller BT, Abrams GD, Vesiliades J, Lucchesi BR. Ventricular fibrillation in a conscious canine preparation of sudden coronary death - prevention by short-and long-term amiodarone administration. Circulation 1983; 68: 857-864.
115. Pearson JW, Redding JS. Influence of peripheral vascular tone on cardiac resuscitation. Anesthesia and Analgesia 1965; 44: 746-752.
116. Pentel P, Benowitz N. Pharmacokinetic and pharmoco-dynamic considerations in drug therapy of cardiac emergencies. Clinical Pharmacokinetics 1984; 9: 273-308.
117. Polster P, Broekhuysen J. The adrenergic antagonism of amiodarone. Biochemical Pharmacology 1976; 25: 131-134.
118. Quinton DN, O'Byrne G, Aitkenhead AR. Comparison of endotracheal and peripheral intravenous adrenaline in cardiac arrest. Lancet 1987; 1: 828-829.
119. Raehl CL. Endotracheal drug therapy in cardiopulmonary resuscitation. Clinical Pharmacy 1986; 5: 572-579.
120. Ralston SH, Tacker WA, Showen L, Carter A, Babbs CF. Endotracheal versus intravenous epinephrine during electromechanical dissociation with CPR in dogs. Annals of Emergency Medicine 1985; 14: 1044-1048.
121. Rasmussen HS, Aurup P, Hojberg S, Jensen EK, McNair P. Magnesium and acute myocardial infarction. Archives of Internal Medicine 1986; 146: 872-874.
122. Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet 1986; 1: 234-236.
123. Redding J, Pearson JW. Resuscitation from ventricular fibrillation. Journal of the American Medical Association 1968; 203: 255-260.
124. Roberts JR, Greenberg MI, Knaub M, Baskin SI. Comparison of the pharmacological effects of epinephrine administered by intravenous and endotracheal routes. Journal of the American College of Emergency Physicians 1978; 7: 260-264.
125. Roberts JR, Greenberg MI, Knaub MA, Kendrick ZV, Baskin SI. Blood levels following intravenous and endotracheal epinephrine administration. Journal of the American College of Emergency Physicians 1979; 8; 53-56.
126. 31P NMR study. Annals of Emergency Medicine 1989; 18: 341-347.
127. Rubertsson S, Grenvik A, Wiklund L. Blood flow and perfusion pressure during open-chest versus closed-chest cardiopulmonary resuscitation in pigs. Critical Care Medicine 1995; 23: 715-725.
128. Rubio PA, Farrell EM. Percutanous infraclavicular sub-; clavian catheterization. Annals of Surgery 1982; 48: 230-231.
129. Sanders AB, Kern KB, Fonken S, Otto CW, Ewy GA. The role of bicarbonate and fluid loading in improving resusctation from prolonged cardiac arrest with rapid manual chest compression CPR. Annals of Emergency Medicine 1990; 19: 1-7.
130. Sanders AB, Otto CW, Kern KB, Rogers JN, Perrault P, Ewy GA. Acid-base balance in a canine model of cardiac arrest. Annals of Emergency Medicine 1988; 17: 667-671.
131. Schleien CL, Berkowitz ID, Traystman R, Rogers MC. Controversial issues in cardiopulmonary resuscitation. Anesthesiology 1989; 71: 133-149.
132. Schoffstall JM, Spivey WH, Davidheiser S, Fuhs L, Kirkpatrick R. Endogenous and exogenous plasma catecholamine levels in cardiac arrest in swine. Resuscitation 1990; 19: 241-251.
133. Schuttler I, Bartsch A, Ebeling BJ, Hornchen U, Kulka P, Suhling B, Stoeckel H. Endobronchiale applicakation von adrenalin in der praklinischen kardiopulmonalen reanimation. Anaesthesie Intensivtherapie Notfallmedizine 1987; 22: 63-68.
134. Scott B, Martin FG, Matchett J, White S. Canine cardiovascular responses to endotracheally and intravenously administered atropine, isoproterenol, and propranolol. Annals of Emergency Medicine 1987; 16: 1-10.
135. Shen WK, Kurachi Y. Mechanism of adenosine mediated actions on cellular and clinical cardiac electrophysiology. Mayo Cinic Procedings 1995; 70: 274-291.
136. Singh BN, Vaughan Williams EM. The effect of amiodarone - a new anti anginal drug - on cardiac muscle. British Journal of Pharmacology 1970; 39: 657-667.
137. Steichen JJ, Kleinman LI. Studies in acid-base balance. I. Effect of alkali therapy in newborn dogs with mechanically fixed ventilation. Journal of Pediatrics 1977; 91: 287-291.
138. Stiell IG, Herbert PC, Weitzman BN, Wells GA, Raman S, Stark RM, Higginson LAJ, Ahuja J, Dickinson GE. High-dose epinephrine in adult cardiac arrest. New England Journal of Medicine 1992; 327: 1045-1050.
139. Stueven H, Thompson BM, Aprahamian C, Darin JC. Use of calcium in prehospital cardiac arrest. Annals of Emergency Medicine 1983; 12: 136-139.
140. Talit U, Braun S, Halkin H, Shargorodsky B, Laniado S. Pharmacokinetic differences between peripheral and central drug administration during cardiopulmonary resuscitation. Journal of the American College of Cardiology 1985; 6: 1073-1077.
141. Taylor SH, Saxton C, Majid PA, Dykes JR, Ghosh P, Stoker JB. Insulin secretion following myocardial infarction with particular respect to the pathogenesis of cardiogenic shock. Lancet 1969; 2: 1373-1378.
142. Vetter NJ, Adams W, Strange RC, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 1: 284-289.
143. Weaver WD, Fahrenbruch CE, Johnson DD, Hallstrom AP, Cobb LA, Copass MK. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990; 82: 2027-2034.
144. Weil MH, Rachow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. New England Journal of Medicine 1986; 315: 153-156.
145. White RD. Antifibrillatory drugs: the case for lidocaine and procainamide. Annals of Emergency Medicine 1984; 13: 802-804.
146. White RD. Defining the pressure needs of the fibrillating heart during prolonged arrest: identification and application. Annals of Emergency Medicine 1985; 14: 587-588.
147. Wiklund I, Jorfeldt L, Stjernstrom H, Rubertsson S. Gas exchange as monitored in mixed venous and arterial blood during experimental cardiopulmonary resuscitation. Acta Anesthesiologica Scandinavica 1992; 36: 427-435.
148. Wildenthal K, Mierzwiak DS, Myers RW, Mitchell JH. Effects of acute lactic acidosis on left ventricular performance. American Journal of Physiology 1968; 214: 1352-1359.
149. Williams ML. Intravenous amiodarone during prolonged resuscitation from cardiac arrest. Annals of Internal Medicine 1989; 110: 839-842.
150. Zimmerman AN, Hulsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membrane of the isolated rat heart. Nature (London) 1966; 211: 646-647.